Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study

被引:0
|
作者
Lindquist, Sofie [1 ]
Kjaer, Susanne K. [1 ,2 ,3 ]
Frederiksen, Kirsten [4 ]
Ornskov, Dorthe [5 ]
Petersen, Lone Kjeld [6 ,7 ]
Munk, Christian [1 ]
Waldstrom, Marianne [8 ,9 ]
机构
[1] Danish Canc Inst, Unit Virus Lifestyle & Genes, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Gynecol, Rigshosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[4] Danish Canc Inst, Unit Stat Biostat & Registry, Copenhagen, Denmark
[5] Odense Univ Hosp, Dept Pathol, Odense, Denmark
[6] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[7] Univ Southern Denmark, Dept Clin Med, Odense, Denmark
[8] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark
[9] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
cervical cancer; cervical intraepithelial neoplasia; HPV testing; human papillomavirus; screening; BIOPSIES;
D O I
10.1111/aogs.14915
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
IntroductionIn Denmark, where human papillomavirus (HPV) -based cervical cancer screening is being implemented, the aim of this pilot implementation study was to test a specific screening algorithm, assess follow-up examination attendance, and measure the proportion of precancer lesions found in relation to the number of women referred for colposcopy.Material and MethodsFrom May 2017 to December 2020, 36 417 women in the uptake area of the Department of Pathology, Vejle Hospital, Region of Southern Denmark, were included in the HPV group. Women positive for HPV16/18 irrespective of cytology and women positive for other high-risk HPV (hrHPV) types having concomitant abnormal cytology were referred directly to colposcopy. Women positive for other hrHPV types and normal cytology were referred to repeat screening after 12 months, and hrHPV negative to routine screening after three years. We obtained information on screening results and subsequent histological diagnosis from the Danish Pathology Databank through September 2022.Results3.6% of the women were referred to colposcopy after primary screening, 5% to repeat screening after 12 months, and 91.4% back to routine screening. High follow-up rates were observed: 96% attended colposcopy after primary screening, with 91% attending colposcopy after repeat screening. CIN3+ was detected at colposcopy following the primary screening in 28.1% of HPV16/18-positive women and 18.2% of those positive for other hrHPV types with concomitant abnormal cytology. Of the women with other hrHPV and simultaneous ASCUS/LSIL, 8% had CIN3+. At the repeat screening, 43% had become hrHPV negative, 55% were persistently positive for other hrHPV, and 2% had turned positive for HPV16/18. At the colposcopy following repeat screening, 10.1% of the women positive for other hrHPV were diagnosed with CIN3+, in comparison with 11.1% of the HPV16/18-positive women.ConclusionsIn this pilot implementation study, an algorithm for HPV-based screening was evaluated in a Danish setting. The results demonstrated high attendance at follow-up examinations and provided insights into the number of colposcopy referrals and the detection of CIN2 and CIN3+ cases. The results suggest that women testing positive for other hrHPV in combination with ASCUS/LSIL at primary screening could potentially be referred to repeat screening instead of an immediate colposcopy. This Danish pilot study assessed an HPV-based screening algorithm, revealing a high follow-up attendance. Positive hrHPV with ASCUS/LSIL may motivate repeat screening after 12 months, potentially reducing immediate colposcopy referrals while maintaining effective detection of CIN2 and CIN3+ cases.image
引用
收藏
页码:1781 / 1788
页数:8
相关论文
共 50 条
  • [1] Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
    Thomsen, Louise T.
    Kjaer, Susanne K.
    Munk, Christian
    Frederiksen, Kirsten
    Ornskov, Dorthe
    Waldstrom, Marianne
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 203 - 213
  • [2] Comparative analysis of HPV testing versus cytology in Danish cervical cancer screening: Insights from a large-scale implementation study
    Lindquist, Sofie
    Kjaer, Susanne K.
    Frederiksen, Kirsten
    Ornskov, Dorthe
    Munk, Christian
    Waldstrom, Marianne
    GYNECOLOGIC ONCOLOGY, 2024, 191 : 45 - 55
  • [3] First international proficiency study on human papillomavirus testing in cervical cancer screening
    Yilmaz, Emel
    Eklund, Carina
    Lagheden, Camilla
    Robertsson, Karin Dahlin
    Lilja, Marina
    Elfstrom, Miriam
    Muhr, Laila Sara Arroyo
    Dillner, Joakim
    JOURNAL OF CLINICAL VIROLOGY, 2023, 167
  • [4] Human Papillomavirus Testing in Cervical Cancer Screening
    Castle, Philip E.
    Cremer, Miriam
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2013, 40 (02) : 377 - +
  • [5] Cervical cancer screening following prophylactic human papillomavirus vaccination
    Franco, Eduardo L.
    Cuzick, Jack
    VACCINE, 2008, 26 : A16 - A23
  • [6] Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
    Kim, Mee-seon
    Lee, Eun Hee
    Park, Moon-il
    Lee, Jae Seok
    Kim, Kisu
    Roh, Mee Sook
    Lee, Hyoun Wook
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (05)
  • [7] The application of human papillomavirus testing to cervical cancer screening
    Lee, HP
    Seo, SS
    YONSEI MEDICAL JOURNAL, 2002, 43 (06) : 763 - 768
  • [8] Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China
    Louise T. Thomsen
    Susanne K. Kjær
    BMC Medicine, 19
  • [9] Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China
    Thomsen, Louise T.
    Kjaer, Susanne K.
    BMC MEDICINE, 2021, 19 (01)
  • [10] Testing for Human Papillomavirus in Cervical Cancer Screening
    Ha Thanh Nishino
    Tambouret, Rosemary H.
    Wilbur, David C.
    CANCER CYTOPATHOLOGY, 2011, 119 (04) : 219 - 227